DOI : https://doi.org/10.18517/ijaseit.12.3.12579

CT-based Analysis of Vascular Tree Abnormalities in Different Phenotypes of COVID-19 Pneumonia

Gihad Ibrahim (1), Ahmed Hassan (2)
(1) Department of Biomedical Engineering, Mashreq University, Khartoum North, Sudan
(2) Department of Telecommunication Engineering, Mashreq University, Khartoum North, Sudan
Fulltext View | Download
How to cite (IJASEIT) :
Ibrahim, Gihad, and Ahmed Hassan. “CT-Based Analysis of Vascular Tree Abnormalities in Different Phenotypes of COVID-19 Pneumonia”. International Journal on Advanced Science, Engineering and Information Technology, vol. 12, no. 3, June 2022, pp. 1215-21, doi:10.18517/ijaseit.12.3.12579.
Citation Format :
In this paper, Computed Tomography (CT) images of six confirmed COVID-19 patients were analyzed in order to investigate the physiological abnormalities in the vascular tree in response to the disease-induced hypoxia. The CT images were classified into an L-type and H-type groups based on the cumulative voxel distribution of the CT scan. A 3-Dimentional model of the vascular tree was reconstructed out of each CT image following a computational framework. Then, the Cross-Sectional Area (CSA) of the vessels belonging to each vascular tree was computed. The acquired results were compared against averaged measurements of three healthy subjects that were computed following the same approach. The results showed that as the severity of COVID-19 lean towards H-type phenotype, signs of vasoconstriction in small blood vessels with a CSA less than 10 mm2 tend to decreases, whereas signs of vasodilation in medium to large blood vessels increases. The intensity of dilated blood vessels proximal to consolidated areas of the lung was found to increase significantly as the disease progresses in the lungs. Furthermore, signs of vasoconstriction and vasodilation in the vascular tree were observed in all lobes of the lung in both phenotypes including seemingly healthy lobes. The results in this paper are suggestive of intrapulmonary blood flow shunting towards unaerated areas of the lungs which may lead to a ventilation/perfusion mismatch even at minor cases of COVID-19. The results also suggest that subject-specific regulated use of vasodilating medication may reduce the number of cases that require mechanical ventilation.

C.-C. Lai, T.-P. Shih, W.-C. Ko, H.-J. Tang, and P.-R. Hsueh, “Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges,” Int. J. Antimicrob. Agents, vol. 55, no. 3, p. 105924, 2020.

D. Wang et al., “Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China,” Jama, vol. 323, no. 11, pp. 1061-1069, 2020.

C. Sohrabi et al., “World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19),” Int. J. Surg., vol. 76, pp. 71-76, 2020.

A. D. T. Force, V. M. Ranieri, G. D. Rubenfeld, B. T. Thompson, N. D. Ferguson, and E. Caldwell, “Acute respiratory distress syndrome,” Jama, vol. 307, no. 23, pp. 2526-2533, 2012.

L. Gattinoni et al., “COVID-19 pneumonia: different respiratory treatments for different phenotypes?,” Intensive Care Med., vol. 46, pp. 1099-1102, 2020.

L. Gattinoni, D. Chiumello, and S. Rossi, “COVID-19 pneumonia: ARDS or not?,” Crit. Care, vol. 24, no. 1, p. 154, 2020, doi: 10.1186/s13054-020-02880-z.

L. Gattinoni, S. Coppola, M. Cressoni, M. Busana, S. Rossi, and D. Chiumello, “Covid-19 does not lead to a ‘typical’ acute respiratory distress syndrome,” Am. J. Respir. Crit. Care Med., vol. 201, no. 10, pp. 1299-1300, 2020.

J. Wang et al., “Tissue plasminogen activator (tPA) treatment for COVID”19 associated acute respiratory distress syndrome (ARDS): a case series,” J. Thromb. Haemost., vol. 8, no. 7, pp. 1752-1755, 2020.

F. Ciceri et al., “Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis,” Crit Care Resusc, vol. 22, no. 2, pp. 95-97, 2020.

F. A. Klok et al., “Incidence of thrombotic complications in critically ill ICU patients with COVID-19,” Thromb. Res., vol. 191, pp. 145-147, 2020.

F. Zhou et al., “Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study,” Lancet, vol. 395, no. 10229, pp. 1054-1062, 2020.

H. Bí¶smí¼ller et al., “The evolution of pulmonary pathology in fatal COVID-19 disease: an autopsy study with clinical correlation,” Virchows Arch., vol. 477, no. 3, pp. 349-357, 2020.

L. Gattinoni, T. Tonetti, and M. Quintel, “Regional physiology of ARDS,” Crit. Care, vol. 21, no. 3, pp. 9-14, 2017.

D. R. Thickett, L. Armstrong, S. J. Christie, and A. B. Millar, “Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome,” Am. J. Respir. Crit. Care Med., vol. 164, no. 9, pp. 1601-1605, 2001.

K. J. Dunham-Snary et al., “Hypoxic pulmonary vasoconstriction: from molecular mechanisms to medicine,” Chest, vol. 151, no. 1, pp. 181-192, 2017.

M. Lang et al., “Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT,” Lancet Infect. Dis., vol. 20, pp. 1365-1366, 2020.

S. Tian, W. Hu, L. Niu, H. Liu, H. Xu, and S.-Y. Xiao, “Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer,” J. Thorac. Oncol., vol. 15, no. 5, pp. 700-704, 2020.

FLUIDDA, “Our War on COVID-19,” 2020. https://www.fluidda.com/covid19/ (accessed May 25, 2020).

J. J. Marini and L. Gattinoni, “Management of COVID-19 respiratory distress,” Jama, vol. 323, no. 22, pp. 2329-2330, 2020, doi: 10.1001/jama.2020.6825.

D. A. Paiva, “Coronacases.org: the first initiative of publicly deploy whole CT scans of covid-19 [CT Datasets],” 2020. https://coronacases.org/ (accessed May 25, 2020).

H. Y. F. Wong et al., “Frequency and distribution of chest radiographic findings in COVID-19 positive patients,” Radiology, p. 201160, 2020.

F. Pan et al., “Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia,” Radiology, vol. 295, pp. 715-721, 2020.

H. Shi et al., “Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study,” Lancet Infect. Dis., vol. 20, no. 4, pp. 425-434, 2020.

S. Kooraki, M. Hosseiny, L. Myers, and A. Gholamrezanezhad, “Coronavirus (COVID-19) outbreak: what the department of radiology should know,” J. Am. Coll. Radiol., vol. 17, no. 4, 2020.

G. Ibrahim, A. Rona, and S. V Hainsworth, “Non-uniform central airways ventilation model based on vascular segmentation,” Comput. Biol. Med., vol. 65, pp. 137-145, 2015.

Y. Sato et al., “Three-dimensional multi-scale line filter for segmentation and visualization of curvilinear structures in medical images,” Med. Image Anal., vol. 2, no. 2, pp. 143-168, 1998.

W. Huang, R. T. Yen, M. McLaurine, and G. Bledsoe, “Morphometry of the human pulmonary vasculature,” J. Appl. Physiol., vol. 81, no. 5, pp. 2123-2133, 1996.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).